Verano Holdings Corp. (VRNO)
| Market Cap | 395.57M +27.7% |
| Revenue (ttm) | 819.87M -5.4% |
| Net Income | -264.22M |
| EPS | -0.73 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 799,505 |
| Average Volume | 960,946 |
| Open | 1.110 |
| Previous Close | 1.090 |
| Day's Range | 1.060 - 1.170 |
| 52-Week Range | 0.460 - 1.950 |
| Beta | 1.43 |
| RSI | 44.22 |
| Earnings Date | Apr 30, 2026 |
About Verano Holdings
Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois. [Read more]
Financial Performance
In 2025, Verano Holdings's revenue was $821.50 million, a decrease of -6.50% compared to the previous year's $878.59 million. Losses were -$257.91 million, -24.56% less than in 2024.
Financial StatementsNews
Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th
Zen Leaf will Honor and Thank the Las Vegas Community with 10 Days of Special Deals for Local Residents, Small Business Support and Special Charity Partnerships, Elvis Lookalike Contests, Giveaways an...
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order
CHICAGO, May 13, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the Company has submi...
Here Is How Marijuana Stocks Are Setting Up To Run In 2026
Investors foresee a potential rise in marijuana stocks leading to another green rush. Anyone who holds shares of cannabis stocks, whether US-based or Canadian, has been battling in the stock market. T...
Verano Holdings Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew sequentially to $208M, driven by retail gains, while wholesale faced margin pressure from promotions and competition. Medical cannabis rescheduling to Schedule III offers immediate tax benefits and supports future growth, with a $20M share repurchase authorized.
Verano Holdings Earnings release: Q1 2026
Verano Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Verano Holdings Slides: Q1 2026
Verano Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Verano Holdings Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew sequentially to $208M, driven by retail gains, while wholesale faced margin pressure from promotions and competition. Medical cannabis rescheduling to Schedule III offers immediate tax benefits and supports future growth, with a $20M share repurchase authorized.
Verano Holdings Earnings release: Q1 2026
Verano Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Verano Holdings Slides: Q1 2026
Verano Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Verano Announces Strong First Quarter 2026 Financial Results Highlighted by $208 Million in Revenue
Company generates revenue growth for second consecutive quarter driven by retail performance and announces $20 million share repurchase authorization CHICAGO, April 30, 2026 (GLOBE NEWSWIRE) -- Verano...
Verano Announces $20 Million Share Repurchase Authorization
CHICAGO, April 30, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that its Board of D...
Verano Holdings ‘celebrates’ cannabis rescheduling to Schedule III
Verano Holdings (VRNO) celebrates announcement that cannabis will be rescheduled from Schedule I to Schedule III in the Controlled Substances Act. CEO George Archos: “We’re thankful for the leadership...
Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III
Verano's active operations span 13 states, comprised of 1 6 2 dispensaries operating under the Zen Leaf ™ and MÜV ™ retail banners, and 1 4 cultivation and processing facilities with more than 1.1 mil...
Verano Expands Retail Presence on Florida's Emerald Coast with Opening of MÜV Miramar Beach, the Company's 85th Florida Dispensary and 162nd Location Nationwide
CHICAGO, April 23, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the grand opening o...
Verano to Report First Quarter 2026 Financial Results on April 30, 2026
CHICAGO, March 25, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to re...
Verano Strengthens Retail Footprint in the Sunshine State with Opening of MÜV Lehigh Acres, the Company's 84th Florida Dispensary and 161st Location Nationwide
CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the grand opening o...
Verano Holdings price target raised to C$5 from C$4 at Canaccord
Canaccord analyst Kenric Tyghe raised the firm’s price target on Verano Holdings (VRNO) to C$5 from C$4 and keeps a Buy rating on the shares.
Verano Holdings price target lowered to C$5 from C$6 at Alliance Global
Alliance Global lowered the firm’s price target on Verano Holdings (VRNO) to C$5 from C$6 and keeps a Buy rating on the shares. Verano announced Q4 sales and EBITDA broadly…
Verano Holdings Earnings Call Transcript: Q4 2025
Reported $822M in 2025 revenue with Q4 sequential growth, despite year-over-year declines from price compression. Secured a $195M term loan, reduced SG&A, and expanded in key markets, positioning for catalysts like federal rescheduling and adult-use launches.
Verano Holdings Earnings release: Q4 2025
Verano Holdings released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Verano Holdings Slides: Q4 2025
Verano Holdings has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
Verano Holdings Earnings Call Transcript: Q4 2025
Reported $822M in 2025 revenue with Q4 sequential growth, despite year-over-year declines from price compression. Secured a $195M term loan, reduced SG&A, and expanded in key markets, positioning for catalysts like federal rescheduling and adult-use launches.
Verano Holdings Earnings release: Q4 2025
Verano Holdings released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Verano Holdings Slides: Q4 2025
Verano Holdings has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
Verano Announces $195 Million Senior Secured Term Loan Refinancing Agreement to Fund Company's Strategic Growth Initiatives
New credit facility highlights Company's ability to access lower-cost regional bank capital and secure among the most favorable terms in the industry, including an initial 9.5% annual interest rate an...